For the history and numbers buffs among us, the industry hit an important milestone by the close of the third quarter last week. Public and private biotech companies have raised a collective $25 billion so far this year. That massive amount vaults the total into second place in the amount of financing dollars raised each year over the past 20 years. Read More
When the curtain closed on the third quarter, 67 global private biotech companies developing biotherapeutics had successfully completed transactions in the period, according to data compiled by BioWorld Snapshots, for a combined total of approximately $1.2 million from the 63 companies that disclosed terms of their deals. That amount, however, represented a significant 33 percent drop from the $1.8 billion raised from 74 deals during the second quarter of 2014. Read More
